Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulins: a phase I/II dose finding study
Sammy Huygens(Ghent University Hospital), Bart Rijnders(Erasmus MC), Birgit C. P. Koch(University Medical Center Groningen), Francis Swaneveld(Sanquin), Ilona Kleine Budde, Corine H. GeurtsvanKessel(Erasmus University Rotterdam), Tim Preijers(Erasmus MC)
Cited by 1
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
|Science Immunology|2021|591
Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells
|The Journal of Experimental Medicine|2008|465
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
|Science Immunology|2022|438